Accelero Receives EU Eurostars Funding Supporting a Gene Therapy for the Treatment of Lypodystrophy
Accelero Bioanalytics GmbH (“Accelero”) is awarded EUR 136,500 in project grants to support research and development of a gene therapy targeting lypodystrophy.
Open Positions Cell Culture & Immunoassays
Accelero is the No. 1 for regulatory ATMP development in the German capital region. For the continuously growing number of exciting research projects, we are seeking technical and scientific support for our GLP test facility in Berlin Adlershof.
